Table 1. Clinical features of patients.

	All patients			Propensity-matched patients
	Group C	Group F	P	Group C	Group F	P
Sex, male/female	72/60	52/43	> 0.99	50/45	52/43	0.89
Age (years), median (IQR)	66.5 (60.0 – 73.0)	68.0 (58.0 – 74.0)	0.54	67.0 (60.0 – 74.0)	68.0 (58.0 – 74.0)	0.89
Tumor size (mm), median (IQR)	27.4 (19.8 – 34.2)	28.3 (21.4 – 37.1)	0.35	27.5 (20.0 – 34.4)	28.3 (21.4 – 37.1)	0.59
Pancreatic head/body or tail	34/98	49/46	< 0.001	24/71	49/46	< 0.001
Transgastric/transduodenal	107/25	48/47	< 0.001	72/23	48/47	< 0.001
Trainee/expert	92/40	88/7	< 0.001	88/7	88/7	> 0.99
Lesions requiring/not requiring immunostaining	15/117	17/78	0.18	10/85	17/78	0.21

IQR, interquartile range; n, number of lesions